Plasma Mucin-1 as a Potential Biomarker for Diabetic Peripheral Neuropathy in Type 2 Diabetes
Biomolecules · 2026
DOI: 10.3390/biom16010128 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2026. Verfasst von Jae-Hyung Park und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, School of Medicine, Keimyung University, Daegu 42601, Republic of Korea. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetic Neuropathies, Mucin-1. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korea Health Industry Development Institute, Korean Government.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Diabetic peripheral neuropathy (DPN) is a major complication of type 2 diabetes mellitus (T2D) that reduces quality of life and increases the risk of foot ulcers and amputations. Early detection is essential, and blood-based biomarkers may support improved screening and timely intervention. This study aimed to identify novel circulating biomarkers for the identification of DPN in patients with T2D.
Methods
In the screening phase, plasma samples from 43 participants (10 healthy volunteers [HV], 20 T2D without complications, and 13 T2D with DPN) were analyzed using an antibody array targeting 310 proteins. Thirteen differentially expressed proteins were identified, and six hub proteins were selected through bioinformatic analysis. In the validation phase, plasma concentrations of the six proteins were measured by ELISA in 252 subjects (100 HV, 97 T2D without complications, and 55 T2D with DPN). Mucin-1 expression in sciatic nerves was further evaluated in db/db mice.
Results
Of the six hub proteins (TGFB1, MUC1, PF4, IL2RA, SELL, B2M), only mucin-1 showed a significant increase in the DPN group. Plasma mucin-1 positively correlated with MNSI scores and negatively with motor and sensory nerve conduction velocities. In db/db mice, sciatic nerve mucin-1 expression was elevated, while CD31 expression was reduced.
Conclusions
Plasma mucin-1 is strongly associated with DPN in both humans and animals and may serve as a promising biomarker for the screening and early identification of DPN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, School of Medicine, Keimyung University, Daegu 42601, Republic of Korea.
- Department of Research, Keimyung University Dongsan Medical Center, Daegu 42601, Republic of Korea.
- Department of Internal Medicine, Keimyung University School of Medicine, Daegu 42601, Republic of Korea.
ORCID-Profile: Jae-Hyung Park, Gyeong Im Yu, Eun Yeong Ha, Hochan Cho
Förderung
- National Research Foundation of Korea
- Korea Health Industry Development Institute
- Korean Government
- the Ministry of Health and Welfare, Republic of Korea
Zitieren
APA
Park, J. H., Nguyen, T. N., Shim, H. M., Yu, G. I., Kang, J., Ha, E. Y., & Cho, H. (2026). Plasma Mucin-1 as a Potential Biomarker for Diabetic Peripheral Neuropathy in Type 2 Diabetes. Biomolecules. https://doi.org/10.3390/biom16010128
Vancouver
Park JH, Nguyen TN, Shim HM, Yu GI, Kang J, Ha EY, et al. Plasma Mucin-1 as a Potential Biomarker for Diabetic Peripheral Neuropathy in Type 2 Diabetes. Biomolecules. 2026. doi:10.3390/biom16010128
BibTeX
@article{Park2026,
author = {Park, Jae-Hyung and Nguyen, Thi Nhi and Shim, Hye Min and Yu, Gyeong Im and Kang, Junho and Ha, Eun Yeong and Cho, Hochan},
title = {Plasma Mucin-1 as a Potential Biomarker for Diabetic Peripheral Neuropathy in Type 2 Diabetes},
journal = {Biomolecules},
year = {2026},
doi = {10.3390/biom16010128}
}
EUVIMED